About
Cachexia Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (17)
Andrew J
Founder and Non-Executive Director
Actimed Therapeutics
founder
Annalisa Jenkins
Advisor
Actimed Therapeutics
advisor
Atish Majumdar
Non-executive Director
Actimed Therapeutics
team_member
Caroline Bradshaw
Head of Quality Consultant
Actimed Therapeutics
team_member
Chika Yoshinaga
Development, Partnering and Financing Advisor in Japan and China
Actimed Therapeutics
advisor
David Ebsworth
Executive Chairman
Actimed Therapeutics
board_chair
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
326
By Phase
PHASE2: 2PHASE1: 4
By Status
TERMINATED: 3RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07101939Lead Sponsor
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During, and Post-semaglutide Therapy
PHASE2Recruiting
48 participants
Started: Jun 23, 2025 · Completed: Sep 30, 2026
NCT05205109Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
PHASE1Recruiting
98 participants
Started: Jun 7, 2022 · Completed: Feb 28, 2028
NCT06028321Lead Sponsor
Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)
PHASE1Completed
51 participants
Started: Nov 26, 2021 · Completed: Jun 2, 2022
NCT04305249Lead Sponsor
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies
PHASE1Terminated
36 participants
Started: Aug 15, 2020 · Completed: May 24, 2024
NCT04281420Lead Sponsor
A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma
PHASE1Terminated
20 participants
Started: Apr 13, 2020 · Completed: Oct 2, 2023
Locations (1)
Headquarters
Berkshire, UK
Map
Loading map...